Aspire Capital to buy up to $20M in NeoStem stock

Aspire Capital Fund agreed to purchase up to $20 million in NeoStem Inc. (NYSE-A:NBS) stock over a two-year period ending Sept. 30, 2013. Aspire will purchase shares at NeoStem's request, with the price set at the lower of the lowest share price on the date of the sale or the average of the three lowest closing prices during the 12 consecutive business days prior to the sale date. Aspire will receive 990,099 shares up front, valued at $643,564 based on NeoStem's close of $0.65 on Friday, before the deal was announced. ...